Leucocyte recruitment induced by type II phospholipases A2 into the rat pleural cavity

Toxicon

Volumn 38, Issue 12, 2000, Pages 1773-1785

  De Castro, R C ^a   Landucci, E C T ^a   Toyama, M H ^a   Giglio, J R ^b   Marangoni, S ^a   De Nucci, G ^a   Antunes, E ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Heparin; Phospholipase A2; Pleurisy; Snake venoms

Indexed keywords

BATROXOBIN; BOTHROPSTOXIN 1; BOTHROPSTOXIN 2; COMPOUND 48-80; HISTAMINE; PHOSPHOLIPASE A2; SEROTONIN; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; MALE; MAST CELL DEGRANULATION; NONHUMAN; PLEURA CAVITY; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; RAT;

ACETOPHENONES; ANIMALS; CELL DEGRANULATION; CHEMOTAXIS, LEUKOCYTE; CROTALID VENOMS; EOSINOPHILS; HISTAMINE; LEUKOCYTE COUNT; MALE; MAST CELLS; NEUTROPHILS; P-METHOXY-N-METHYLPHENETHYLAMINE; PHOSPHOLIPASES A; PLEURA; RATS; RATS, WISTAR; SEROTONIN;

ANIMALIA; BOTHROPS JARARACUSSU; BOTHROPS PIRAJAI; SERPENTES;

EID: 0034594344     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(00)00107-0     Document Type: Article

References (49)

1. 2 in psoriatic tissue. Inflammation. 18:1994;1-12.
2. 2. Proc. Natl. Acad. Sci. USA. 95:1998;7951-7956.
3. 2 induced an inflammatory response in rabbit joints. J. Immun. 146:1991;3904-3910.
4. 2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon. 36:1998;1861-1869.
5. 2-induced rat mast cell secretion. Role of arachidonic acid metabolites. Lab. Invst. 47:1982;579-585.
6. 2 purified from Trimeresurus mucrosquamatus snake venom. Toxicon. 27:1989;115-125.
7. Cintra A.C.O., Marangoni S., Oliveira B., Giglio J.R. Bothropstoxin-I: Amino acid sequence and function. J. Prot. Chem. 12:1993;57-64.
8. 2-induced oedema in rat paw. Eur. J. Pharmac. 166:1989;505-510.
9. 2 induces a synovitis-like inflammation in the rat air pouch. J. Rheumat. 21:1994;824-829.
10. Coleman J.W., Holgate S.T., Church M.K., Godfrey R.C. Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Biochem. J. 198:1981;615-619.
11. 2. J. Biol. Chem. 269:1994;13057-13060.
12. Di Rosa M., Giroud J.P., Willoughby D.A. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turpentine. J. Path. 104:1971;15-29.
13. 2. Biochim. Biophys. Acta. 28:1998;253-266.
14. Formela L.J., Galloway S.W., Kingsnorth A.N. Inflammatory mediators in acute pancreatitis. Br. J. Surg. 82:1995;6-13.
15. 2 enzymes: regulation and inhibition. Trends Pharmac. Sci. 14:1993;92-98.
16. 2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273:1998;606-612.
17. Homsi-Brandeburgo M.I., Queiroz L.S., Santo-Neto H., Rrodrigues-Simioni L., Giglio J.R. Fractionation of Bothrops jararacussu snake venom: Partial chemical characterization and biological activity of bothropstoxin. Toxicon. 26:1988;615-627.
18. 2 in atherosclerosis. Atherosclerosis. 11:1997;1-8.
19. 2 in rat renal mesangial cells. Biochim. Biophys. Acta. 1348:1997;257-272.
20. 2 inhibition by alkylbenzoylacrylic acids. Biochem. Pharmac. 44:1992;805-813.
21. Kyger E.M., Franson R.C. Nonspecific inhibition of enzymes by p-bromophenacyl bromide. Inhibition of human platelet phospholipace C and modification of sulfhydryl groups. Biochim. Biophys. Acta. 794:1984;96-103.
22. 4 secretagogue for human polymorphonuclear leukocytes. Adv. Exp. Med. Biol. 275:1990;183-191.
23. 2. Trends Pharmac. Sci. 20:1999;162-170.
24. 2 homologues: Dissociation between enzymatic and biological activities. Eur. J. Pharmac. 343:1998;257-263.
25. 2 homologue piratoxin-I in the rat and rabbit: effect of polyanions and p-bromophenacyl bromide, Biochem. Pharmac. 59 (in press).
26. 2 enzymes on mast cells of rat, guinea pig and human. Inflamm. Res. 46:1997;S19-20.
27. 2 purified from porcine pancreas and snake venoms. Toxicon. 31:1993;949-956.
28. 2 activity by a colorimetric assay using a pH indicator. Toxicon. 25:1987;1181-1188.
29. Lomonte B., Tarkowski A., Hanson L.A. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation. 17:1993;93-105.
30. Mancuso L.C., Correa M.M., Vieira C.A., Cunha O.A.B., Lachat J.J., Selistre H.A.S., Ownby C.L., Giglio J.R. Fraction of Bothrops pirajai snake venom: Isolation and characterization of piratoxin-I, a new myotoxic protein. Toxicon. 33:1995;615-626.
31. Martins M.A., Pasquale C.P., Silva P.M., Cordeiro R.S., Vargaftig B.B. Eosinophil accumulation in the rat pleural cavity after mast cell stimulation with compound 48/80 involves protein synthesis and is selectively suppressed by dexamethasone. Int. Arch. Allergy Appl. Immun. 92:1990;416-424.
32. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 77:1997;1033-1079.
33. 2-induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action. Agents Actions. 36:1992;258-263.
34. 2, eicosanoid release and cellular accumulation in rat immunological air pouch inflammation. Int. J. Immunopharmac. 15:1993;597-603.
35. 2. J. Immun. 151:1993;5675-5684.
36. 2-induced inflammation. Inflammation. 17:1993;205-215.
37. 2 proteins. Toxicon. 37:1999;411-445.
38. 2 activity. J. Protein Chem. 17:1998;381-386.
39. 2 in Clinical Inflammation: Molecular Approaches to Pathophysiology. vol. 5:1995;93-124 CRC Press, New York.
40. 2 in rabbits. J. Invest. Dermat. 86:1986;380-383.
41. 2 correlates with disease activity in rheumatoid arthritis. J. Rheumat. 15:1988;1351-1356.
42. 2 covalently inhibited by p-bromo-phenacyl-bromide. J. Mol. Biol. 200:1988;181-188.
43. 4 by human leucocytes in vitro. Pancreas. 9:1994;37-41.
44. Toyama M., Mancuso L.C., Giglio J.R., Novello J.C., Oliveira B., Marangoni S. A quick procedure for the isolation of dimeric piratoxins-I and II, two myotoxins from Bothrops pirajai snake venom. N-terminal sequencing. Biochem. Mol. Biol. Int. 37:1995;1047-1055.
45. 2 levels correlation with the hemodynamic and pulmonary changes in Gram-negative septic shock. J. Lab. Clin. Med. 104:1984;873-877.
46. 2. Am. J. Path. 134:1989;807-811.
47. 2. Biochemistry. 13:1974;1446-1454.
48. 2 enzymes. Eur. J. Pharmac. 190:1990;347-354.
49. 2 modified by p-bromo-phenacyl-bromide. Toxicon. 36:1988;875-886.